Recurrent Glioblastoma
Recurrent glioblastoma is a type of aggressive brain tumor that returns after treatment. It is known for its rapid growth and can cause severe symptoms affecting brain function.
Glioblastoma: Radiodynamic Therapy with 5-Aminolevulinic Acid
We are testing a new treatment combining radiodynamic therapy and 5-Aminolevulinic acid for patients with a first recurrence of glioblastoma. The goal is to find the highest safe dose and ensure it can be tolerated.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have a history of severe heart problems or poorly controlled diabetes?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications that can cause sensitivity to light, like tetracyclines or St. John's wort?
- Have you had a recurrence of glioblastoma after initial treatment?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaet Muenster
Neurochirurgie
Münster, Germany
Sponsor: Universitaet Muenster
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.